Looking Back at 2022: Top 5 Stories About Cancer Research and Cancer Care
My picks for five of the top cancer research stories of 2022.
5 Cancer Research Stories Worth Following – Spring 2018
Researchers are working on ways to make immune system therapies more effective for more cancer patients.
Making Healthcare More Affordable: Review of “An American Sickness” by Elisabeth Rosenthal
In ‘An American Sickness’, Elisabeth Rosenthal explains why our healthcare costs are out of control and offers practical steps we can take as individuals as well as a blueprint for reforms.
5 Cancer Research Stories Worth Following – Winter 2018
Cancer research stories worth following this winter included reports on new approaches to immunotherapy currently being tested in clinical trials.
5 Cancer Research Stories Worth Following – Fall 2017
Recent cancer research stories worth following include a study on post-traumatic stress disorder after a cancer diagnosis.
Genetic Testing for Cancer Risk: My Experience and What I Learned
What my experience with genetic testing was like and some of the helpful things I learned in the process.
Making a Difference: Contributing to Cancer Charities
We can make a difference in the fight against breast cancer by contributing to highly rated breast cancer and cancer research charities.
5 Cancer Research Stories Worth Following – Summer 2017
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
Blogging Challenge: My Answers to 10 Random Questions About Cancer
I’m taking up a blogging challenge in which participants are asked to give their answers to “10 random questions about cancer.”
Charity Review: Cancer Research Institute
The Cancer Research Institute fosters research in cancer immunology to develop more effective life-saving treatments for all types of cancer.
A Role for Progesterone in Breast Cancer Treatment?
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
After 20 Years 